FTRE
Fortrea Holdings Inc.
Biotechnology · Healthcare · United States
17.82
close · 2026-08-13
value
73
cheaper than peers73
quality
37
stronger fundamentals37
ranked against
Biotechnology (commercial)
value
quality
101 peerswide variation
Value inputs
| measure | company | vs peers |
| price to sales | 0.63× | 100 |
| price to book | 3.23× | 69 |
| forward P/E | 15.65× | 62 |
| EV to EBITDA | 28.09× | 41 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | 2.6% | 76 |
| return on equity | -15.3% | 67 |
| revenue growth | -4.5% | 25 |
| debt to equity | 213.2% | 13 |
4 of 4 measures available
Facts
| market cap | $2B |
| free cash flow | $278.9M |
| employees | 14,000 |
| first trade | 2023-06-16 |
| next earnings | 2026-07-29 |
| fundamentals updated | 2026-08-06 |